Vivatmo® Pro FeNO Monitoring Device Handheld Nitric Oxide Monitor
Measure airway inflammation in seconds with a portable fractional exhaled nitric oxide (FeNO) device engineered by Bosch for respiratory clinics and pulmonary laboratories.
Vivatmo® Pro FeNO Monitoring Device Handheld Nitric Oxide Monitor
Measure airway inflammation in seconds with a portable fractional exhaled nitric oxide (FeNO) device engineered by Bosch for respiratory clinics and pulmonary laboratories.
Providers
Accurate FeNO results in seconds to assess airway inflammation and guide treatment.
Labs
Easy to implement, simple to use, and built to fit seamlessly into your lab.
Patients
A quick non-invasive breath test that helps your provider personalize your care.
Why choose Vivatmo® Pro?
Accurate
High precision FeNO measurements you can trust.
Fast
Results in seconds to support real-time decision making.
Portable
Lightweight, handheld design for use anywhere care happens.
Easy to use
Minimal training and simple maintenance.
Evidence-based
Supported by clinical studies and guideline recommendations.
FeNO Diagnostics for Healthcare Providers & Pulmonologists
Measure airway inflammation quickly and objectively to support asthma diagnosis and ongoing management. Vivatmo Pro provides rapid FeNO results at the point of care.
Clinical Applications
Monitor response to anti-inflammatory therapy ²
Support asthma diagnosis ²
Monitor response to anti-inflammatory therapy ²
Aid treatment decision-making ²
Benefits
Results in seconds
Portable, point-of-care device
Simple to operate
Non-invasive test
Integrating FeNO Testing into Pulmonary Function Laboratories
Integrate FeNO testing into your respiratory diagnostics workflow with Vivatmo Pro, designed for efficient operation.
Laboratory Benefits
Assess eosinophilic airway inflammation
Support asthma diagnosis
Monitor response to anti-inflammatory therapy
Aid treatment decision-making
Resources
Instructions & Important Information
Operational & Setup Guides
For Patients
A FeNO test (fractional exhaled nitric oxide test) measures the level of nitric oxide in a person’s breath. This provides an indication of airway inflammation, which is commonly associated with asthma.¹
What to Expect
The test takes only a few minutes
Simply breathe into the mouthpiece
No needles or blood tests
Results are available immediately
Frequently Asked Questions
What is a FeNO test and how does it measure airway inflammation?
A FeNO test (fractional exhaled nitric oxide test) measures the level of nitric oxide in a person’s breath. This provides an indication of airway inflammation, which is commonly associated with asthma.
FeNO testing is used by healthcare providers to support asthma diagnosis, assess inflammation in the airways, and help guide treatment decisions, particularly the use of inhaled corticosteroids.
How does Vivatmo® Pro work?
Vivatmo® Pro measures fractional exhaled nitric oxide (FeNO) in a patient’s breath sample using a simple, non-invasive breathing test.
The patient exhales into the device, which then provides a FeNO measurement within seconds. This allows healthcare professionals to assess airway inflammation in asthma patients quickly and objectively.
What is Vivatmo® Pro used for?
Vivatmo® Pro is used to support the assessment and management of asthma and airway inflammation through FeNO testing.
It helps healthcare providers identify type 2 airway inflammation, support asthma diagnosis in appropriate patients, monitor response to anti-inflammatory therapy and guide treatment decisions, including inhaled corticosteroid use.
It is commonly used in pulmonology and allergy practices as part of asthma management.
Is FeNO testing painful or invasive?
No. FeNO testing with Vivatmo® Pro is completely non-invasive and painless. The test simply requires the patient to breathe into the device for a few seconds. This makes FeNO testing suitable for both adults and children in routine asthma assessment and monitoring.
How long does a FeNO test take?
A FeNO test using Vivatmo® Pro typically takes only a few minutes from start to result. The actual breath measurement is completed in seconds, making it a fast and efficient tool for point-of-care asthma evaluation in busy clinical settings.
Who should receive FeNO testing?
FeNO testing is recommended for patients where asthma or airway inflammation is suspected or being monitored.²
It is commonly used in:
- patients with suspected asthma symptoms
- individuals with uncontrolled or difficult-to-manage asthma
- patients being evaluated for inhaled corticosteroid therapy
- follow-up of asthma control and treatment response
Clinical guidelines, including ATS/ERS recommendations, support the use of FeNO testing as part of a broader asthma management strategy.
What is FeNO testing used for in asthma?
FeNO testing is used to assess airway inflammation in asthma patients. It helps clinicians determine whether inflammation is present and whether a patient is likely to respond to anti-inflammatory treatments such as inhaled corticosteroids.
FeNO testing is increasingly used in asthma diagnosis and management guidelines, particularly for identifying type 2 (eosinophilic) airway inflammation.
References
- Lommatzsch M, et al. Eosinophils in asthma phenotypes: perpetrators or guilty by association? Lancet Respir Med. 2025;13(10):943-950
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2025. Updated May 2025. Available from: www.ginasthma.org.
- McDowell PJ, Heaney LG. Different endotypes and phenotypes drive the heterogeneity in severe asthma. Allergy. 2020;75(2):302–310.